ECX — Epigenomics AG Share News
0.000.00%
Last trade - 00:00- €0.61m
- -€2.62m
- €0.49m
Brief: Epigenomics Successfully Raises EUR 22.3 Mln In Capital Increase
Brief: Epigenomics Sets Subscription Price At EUR 1.86 Per New Share
Brief: Epigenomics Resolves Capital Increase
Brief: Epigenomics Plans To Increase Share Capital With Subscription Rights For Existing Shareholders
Brief: Epigenomics Q2 Net Loss Shrinks To EUR 2.6 Mln
Brief: Epigenomics: Liquid Biopsy Test For Liver Cancer Detection To Obtain CE Mark
Brief: Epigenomics: Centers For Medicare & Medicaid Services Publish Preliminary Rate Of $192 Per Epi proColon Test
German stocks - Factors to watch on June 11
Brief: Epigenomics Q1 Net Loss Increased To EUR 3.2 Mln
Brief: Epigenomics: Blood Test Shows Promise In The Detection Of Liver Cancer
Brief: Epigenomics: Cumulative Loss Of More Than Half Of Nominal Share Capital
Brief: Epigenomics FY Net Loss Narrows To EUR 10.2 Million
Brief: Epigenomics Gets Ce-Ivd Mark For Lung Cancer Test Epi Prolung
Brief: Epigenomics announces recent payment decision by CMS
Brief: Epigenomics Q3 EBITDA loss narrows to 2.0 million euros
Brief: Epigenomics issues new shares by way of private placement
Brief: Epigenomics says issues convertible bonds
Brief: Epigenomics Q2 net loss widens to 4.1 million euros
Brief: Epigenomics says incurred loss of more than half of nominal share capital of co